These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7246583)

  • 1. Urinary excretion of reduced metabolites of digoxin.
    Lindenbaum J; Tse-Eng D; Butler VP; Rund DG
    Am J Med; 1981 Jul; 71(1):67-74. PubMed ID: 7246583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased digoxin cardioinactive-reduced metabolites after administration as an encapsulated liquid concentrate.
    Rund DG; Lindenbaum J; Dobkin JF; Butler VP; Saha JR
    Clin Pharmacol Ther; 1983 Dec; 34(6):738-43. PubMed ID: 6641088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability of steady-state digoxin kinetics during administration of tablets or capsules.
    Johnson BF; Lindenbaum J; Budnitz E; Marwaha R
    Clin Pharmacol Ther; 1986 Mar; 39(3):306-12. PubMed ID: 3948469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of difference in digoxin urinary excretion with two intravenous infusion rates.
    Lindenbaum J; Long R; Wenger T; Mallis G; Cato A
    Clin Pharmacol Ther; 1981 Sep; 30(3):317-20. PubMed ID: 7273595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of digoxin by the gut flora: reversal by antibiotic therapy.
    Lindenbaum J; Rund DG; Butler VP; Tse-Eng D; Saha JR
    N Engl J Med; 1981 Oct; 305(14):789-94. PubMed ID: 7266632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development and application of a radioimmunoassay for dihydrodigoxin, a digoxin metabolite.
    Butler VP; Tse-Eng D; Lindenbraum J; Kalman SM; Preibisz JJ; Rund DG; Wissel PS
    J Pharmacol Exp Ther; 1982 Apr; 221(1):123-31. PubMed ID: 7062278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of digoxin by Eubacterium lentum, an anaerobe of the human gut flora.
    Dobkin JF; Saha JR; Butler VP; Neu HC; Lindenbaum J
    Trans Assoc Am Physicians; 1982; 95():22-9. PubMed ID: 7182977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excretion of digoxin and its metabolites in urine after a single oral dose in healthy subjects.
    Magnusson JO; Bergdahl B; Bogentoft C; Jonsson UE; Tekenbergs L
    Biopharm Drug Dispos; 1982; 3(3):211-8. PubMed ID: 7139062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The measurement of urinary digoxin and dihydrodigoxin by radioimmunoassay and by mass spectroscopy.
    Greenwood H; Snedden W; Hayward RP; Landon J
    Clin Chim Acta; 1975 Jul; 62(2):213-24. PubMed ID: 1170963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption of beta-methyl-digoxin determined after a single dose and under steady state conditions.
    Boerner D; Olcay A; Schaumann W; Weiss W
    Eur J Clin Pharmacol; 1976 Feb; 9(4):307-14. PubMed ID: 971714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative bioavailability of three pharmaceutical forms of digoxin].
    Thebault J; Lucas A; d'Athis P; Tillement JP
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):144-7. PubMed ID: 576592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of digoxin and beta-methyl-digoxin.
    Padeletti L; Fantini F; Cinelli P; Gremigni C
    J Int Med Res; 1976; 4(5):352-4. PubMed ID: 1028636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dose on bioavailability of oral digoxin.
    Ochs HR; Bodem G; Greenblatt DJ
    Eur J Clin Pharmacol; 1981 Jan; 19(1):53-5. PubMed ID: 7461024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biological availability of digoxin and beta-acetyldigoxin after single-dose administration (author's transl)].
    Clasen R; Kemmeter H; Gilfrich HJ
    Dtsch Med Wochenschr; 1979 Apr; 104(15):543-6. PubMed ID: 436626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased metabolism to dihydrodigoxin after intake of a microencapsulated formulation of digoxin.
    Magnusson JO; Bergdahl B; Bogentoft C; Gustafsson S; Jonsson UE
    Eur J Clin Pharmacol; 1984; 27(2):197-202. PubMed ID: 6499898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of beta-methyldigoxin in healthy humans II: Oral studies and bioavailability.
    Hinderling PH; Garrett ER; Wester RC
    J Pharm Sci; 1977 Mar; 66(3):314-25. PubMed ID: 845795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of different lots of digoxin tablets from the same manufacturer.
    Lindenbaum J
    Clin Pharmacol Ther; 1975 Mar; 17(3):296-301. PubMed ID: 1091397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of bioavailability and enteral absorption of digoxin, beta-acetyldigoxin and beta-methhyldigoxin. Measurement of cumulative renal excretion after a single application (author's transl)].
    Greeff K; Hafner D; Strobach H; Wirth KE
    Arzneimittelforschung; 1977; 27(12):2358-64. PubMed ID: 580051
    [No Abstract]   [Full Text] [Related]  

  • 19. The comparative bioavailability of Lanoxin tablets and Lanoxicaps with and without sorbitol.
    O'Grady J; Johnson BF; Bye C; French J
    Eur J Clin Pharmacol; 1978 Dec; 14(5):357-60. PubMed ID: 729628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased bioavailability of digoxin due to antacids and kaolin-pectin.
    Brown DD; Juhl RP
    N Engl J Med; 1976 Nov; 295(19):1034-7. PubMed ID: 972657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.